10 mg/mL
5 mL bottleUp to eight doses a month
Metered nasal spray. About $24.88 a dose at eight doses a month.
$99.50first month, then $199
Start at 10 mg/mLPT-141 Nasal Spray5 mL bottle · 30-day package
From $99.50 first monthGet started
About $24.88 a dose
PT-141 · metered nasal spray
Thirty minutes ahead, and the evening is yours.
PT-141 nasal spray, 10 mg/mL in a 5 mL bottle. Eight doses a month.
Absorbed through the nose and aimed at the melanocortin pathway, the one that drives desire. Use it 30 to 60 minutes before, up to eight times a month.
- 10 mg/mL in a 5 mL, 30-day bottle
- Timed 30 to 60 minutes before
- Up to eight doses a month
- The Rebody route with published human intranasal research
$99.50 your first month, then $199 monthly.
Metered nasal sprayNeedle-free route
Up to eight doses a monthTaken as needed
U.S. pharmacyCompounded to order
Free deliveryPlain packaging
The bottle
One strength. One bottle. Eight doses a month.
10 mg/mL in 5 mL, prepared to order by a licensed U.S. compounding pharmacy and shipped in plain packaging.
The price covers the online visit, the licensed provider review, the medication, and free delivery. Your prescription label carries the number of sprays your provider directs per dose.
Why the spray
The route the early human research actually used.
Before bremelanotide became an injection, it was studied intranasally in people. That is a real reason to pick this route, and it is the only Rebody PT-141 format that can say it.
- 01A window you can plan around
Thirty to sixty minutes ahead. Long enough to be deliberate, short enough that the evening is still the evening.
- 02Nothing to dissolve, nothing to inject
A metered pump on a small glass bottle. It lives in a drawer and it travels in a bag.
- 03Eight doses a month
As-needed, not daily. There is nothing to take on the nights you do not want it.
The intranasal research
Two published human studies used this route.
Both were run by the group that developed the compound, both were placebo-controlled, and both were small. Here is what they measured.
Women, 2006
18 women, one 20 mg intranasal dose, crossover design
Premenopausal women with female sexual arousal disorder received a single 20 mg intranasal dose and placebo in separate in-clinic sessions. More women reported moderate or high sexual desire after bremelanotide than after placebo (P = 0.0114). Among those who attempted intercourse within 24 hours, significantly more were satisfied with their level of arousal (P = 0.0256). Vaginal vasocongestion did not change significantly.
Diamond LE et al. J Sex Med. 2006;3(4):628-638. A research formulation at a research dose, not the Rebody bottle.Men, 2004
Healthy men and men with mild-to-moderate erectile dysfunction
Intranasal PT-141 produced a statistically significant erectile response versus placebo at doses above 7 mg, with the first erection beginning at roughly 30 minutes. Median time to peak concentration was 0.50 hours and half-life ran 1.85 to 2.09 hours. Flushing and nausea were the most common adverse events.
Diamond LE et al. Int J Impot Res. 2004;16(1):51-59. A research formulation at a research dose, not the Rebody bottle.The approved product
1,267 women, two phase 3 trials, 24 weeks
The RECONNECT trials tested 1.75 mg subcutaneous bremelanotide as needed in premenopausal women with hypoactive sexual desire disorder. Desire scores rose (integrated 0.35, P<.001) and distress about low desire fell (integrated −0.33, P<.001) against placebo.
Kingsberg SA et al. Obstet Gynecol. 2019;134(5):899-908. That is the injection, a different product from this spray.Intimacy results
Desire can feel present again—not scheduled around a product.
Verified Rebody customers on the pt-141 nasal spray.
01
The PT-141 spray took a couple tries to get the timing right but once I did I noticed a real difference. I feel more interested and present instead of stuck in my head. The instructions were clear and my Rebody doctor answered my question without making it awkward.
02
The PT-141 spray has helped with interest and I am initiating more often now. I did have a mild headache the first few times which made me nervous. I messaged my Rebody doctor and got a useful answer about timing and what to watch for. No major issues since.
03
I almost did not write a review because this is such a private topic, but maybe it will help someone else. My desire had been gone for a long time and it was creating distance between my husband and me. My Rebody doctor treated me with kindness and zero judgment, and the PT-141 spray has made intimacy feel natural and spontaneous again. The change in our relationship has been incredible. I am deeply grateful for the care I received.
What your label decides
The bottle is fixed. The directions are yours.
The strength, the volume, and the monthly limit are set by the product. How many sprays you take per dose, and how you store the bottle, are written on the prescription label your provider signs.
Where it is made
One bottle, one prescription, one name on it.
Kaduceus, a licensed 503A compounding pharmacy in the United States, prepares your spray. A 503A pharmacy compounds against a prescription written for one patient, so the bottle carries your name, your active, and your strength.
- Licensed 503A compounding pharmacy
- Compounded in the United States
- Made to your prescription, not to a shelf
- One active, at the strength printed on your label
Getting it
One visit, and then it just arrives.
You answer the questions once. Refills follow on your plan without another visit.
- 01
Answer the private questions
Desire, medicines, blood pressure, heart history, and what you have already tried. No appointment and no waiting room.
- 02
A licensed provider reads it
A U.S.-licensed clinician reviews your history and decides the route and the strength that fit you.
- 03
The pharmacy makes it
A licensed U.S. compounding pharmacy prepares your PT-141 and ships it in plain packaging.
- 04
Keep the thread open
Message your care team about timing, strength, side effects, or refills. Pause or cancel whenever you want.
The other route
PT-141 Troches is here too.
You want the cheapest way in and two strengths to choose from. 8 troches · 30-day package, from $54.50 for the first month.
See the troche
PT-141 Nasal Spray questions
Know the bottle before you start.
Timing, package, research, and how a route change works.
When do I use the nasal spray?
At least 30 to 60 minutes before sexual activity, up to eight doses in a month. Keep the bottle refrigerated between doses. Your prescription label carries the number of sprays per dose your provider writes for you.
How long does a bottle last?
The 5 mL, 10 mg/mL bottle is dispensed as a 30-day package with a limit of eight doses in that month.
What research backs the nasal route?
Two small placebo-controlled human studies used intranasal bremelanotide: 18 premenopausal women with sexual arousal disorder in 2006, and healthy men plus men with mild-to-moderate erectile dysfunction in 2004. Both used research formulations at research doses and neither tested Rebody's bottle or its directions.
Is this the same as Vyleesi?
No. Vyleesi is the FDA-approved 1.75 mg bremelanotide autoinjector for acquired, generalized hypoactive sexual desire disorder in premenopausal women. The Rebody nasal spray is a compounded prescription medication. It is a different product and it does not carry that approval or that indication.
Will it make my nose sting?
Nasal irritation is possible with any nasal spray. Flushing and nausea were the most common adverse events in the published intranasal studies. Message your care team if anything is bothering you.
Can I switch to the troche?
Yes, and it costs less. Message your care team and a provider reviews the route change.
Important safety information
What a provider needs to know before prescribing.
Bremelanotide's approved label is contraindicated in uncontrolled high blood pressure and in known cardiovascular disease. Tell your provider your blood pressure, your heart history, every medicine and supplement you take, whether you take naltrexone, and whether you are pregnant or breastfeeding.
Nausea, flushing, and headache were the reactions most often reported in bremelanotide trials. The approved label also covers a temporary rise in blood pressure, a fall in heart rate, and darkening of skin in patches. Get urgent care for hives, swelling, trouble breathing, chest tightness, or fainting.
The FDA-approved bremelanotide product is Vyleesi, a 1.75 mg subcutaneous autoinjector for acquired, generalized hypoactive sexual desire disorder in premenopausal women. Rebody's troche and nasal spray are compounded prescription medications. They are a different product and they do not carry that approval or that indication.
Compounded medications are not FDA-approved or evaluated by the FDA for safety, efficacy, or quality. Prescription treatment requires a provider decision and is not available in every state.PT-141 Nasal Spray
Set the timer once and forget the negotiation.
$99.50 for your first month, then $199. The visit, the provider review, and delivery are in the price.